Daniel Martins Moreira

Daniel Martins Moreira

Auto-generated profile, based on publicly available information

Daniel Martins Moreira

Department of Urology, University of Illinois at Chicago, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LMLuca Morgantini
Luca Morgantini
UNUshasi Naha
Ushasi Naha
HWHeng Wang
Heng Wang
SFSimone Francavilla
Simone Francavilla
ÖAÖmer Acar
Ömer Acar
SWStevan M. Weine
Stevan M. Weine
Healthcare professionals (HCPs) on the front lines against COVID-19 may face increased workload and stress. Understanding HCPs’ risk for burnout is critical to supporting HCPs and maintaining the quality of healthcare during the pandemic. To assess exposure, perceptions, workload, and possible burnout of HCPs during the COVID-19 pandemic we conducted a cross-sectional survey. The main outcomes and measures were HCPs’ self-assessment of burnout, indicated by a single item measure of emotional exhaustion, and other experiences and attitudes associated with working during the COVID-19 pandemic. A total of 2,707 HCPs from 60 countries participated in this study. Fifty-one percent of HCPs reported burnout. Burnout was associated with work impacting household activities (RR = 1·57, 95% CI = 1·39–1·78, P<0·001), feeling pushed beyond training (RR = 1·32, 95% CI = 1·20–1·47, P<0·001), exposure to COVID-19 patients (RR = 1·18, 95% CI = 1·05–1·32, P = 0·005), and making life prioritizing decisions (RR = 1·16, 95% CI = 1·02–1·31, P = 0·03). Adequate personal protective equipment (PPE) was protective against burnout (RR = 0·88, 95% CI = 0·79–0·97, P = 0·01). Burnout was higher in high-income countries (HICs) compared to low- and middle-income countries (LMICs) (RR = 1·18; 95% CI = 1·02–1·36, P = 0·018). Burnout is present at higher than previously reported rates among HCPs working during the COVID-19 pandemic and is related to high workload, job stress, and time pressure, and limited organizational support. Current and future burnout among HCPs could be mitigated by actions from healthcare institutions and other governmental and non-governmental stakeholders aimed at potentially modifiable factors, including providing additional training, organizational support, and support for family, PPE, and mental health resources.

1 June 2013 in Urology
Verified
Journal Article
Closed access
ZOZhamshid Okhunov
Zhamshid Okhunov
JFJustin I. Friedlander
Justin I. Friedlander
AGArvin K. George
Arvin K. George
BDBrian D. Duty
Brian D. Duty
DMDaniel M. Moreira
Daniel M. Moreira
ZOZeph Okeke
Zeph Okeke

1 December 2014 in European Urology
Verified
Journal Article
Closed access
FIFarhad Islami
Farhad Islami
DMDaniel M. Moreira
Daniel M. Moreira
PBPaolo Boffetta
Paolo Boffetta
SFStephen J. Freedland
Stephen J. Freedland

19 February 2016 in Journal of Urology
Verified
Journal Article
Closed access
PSParas H. Shah
Paras H. Shah
DMDaniel M. Moreira
Daniel M. Moreira
ZOZhamshid Okhunov
Zhamshid Okhunov
VPVinay R. Patel
Vinay R. Patel
SCSameer Chopra
Sameer Chopra
LKLouis R. Kavoussi
Louis R. Kavoussi
The clinical significance of a positive surgical margin after partial nephrectomy remains controversial. The association between positive margin and risk of disease recurrence in patients with clinically localized renal neoplasms undergoing partial nephrectomy was evaluated. A retrospective multi-institutional review of 1,240 patients undergoing partial nephrectomy for clinically localized renal cell carcinoma between 2006 and 2013 was performed. Recurrence-free survival was estimated using the Kaplan-Meier method and evaluated as a function of positive surgical margin with the log rank test and Cox models adjusting for tumor size, grade, histology, pathological stage, focality and laterality. The relationship between positive margin and risk of relapse was evaluated independently for pathological high risk (pT2-3a or Fuhrman grades III-IV) and low risk (pT1 and Fuhrman grades I-II) groups. A positive surgical margin was encountered in 97 (7.8%) patients. Recurrence developed in 69 (5.6%) patients during a median followup of 33 months, including 37 (10.3%) with high risk disease (eg pT2-pT3a or Fuhrman grade III-IV). A positive margin was associated with an increased risk of relapse on multivariable analysis (HR 2.08, 95% CI 1.09-3.97, p=0.03) but not with site of recurrence. In a stratified analysis based on pathological features, a positive surgical margin was significantly associated with a higher risk of recurrence in cases considered high risk (HR 7.48, 95% CI 2.75-20.34, p <0.001) but not low risk (HR 0.62, 95% CI 0.08-4.75, p=0.647). Positive surgical margins after partial nephrectomy increase the risk of disease recurrence, primarily in patients with adverse pathological features.

1 November 2012 in European Urology
Verified
Journal Article
Closed access
RMRoberto L. Muller
Roberto L. Muller
LGLeah Gerber
Leah Gerber
DMDaniel M. Moreira
Daniel M. Moreira
GAGerald Andriole
Gerald Andriole
RCRamiro Castro-Santamaria
Ramiro Castro-Santamaria
SFStephen J. Freedland
Stephen J. Freedland

1 December 2014 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
AVAdriana C. Vidal
Adriana C. Vidal
LHLauren E. Howard
Lauren E. Howard
DMDaniel M. Moreira
Daniel M. Moreira
RCRamiro Castro-Santamaria
Ramiro Castro-Santamaria
GAGerald L. Andriole
Gerald L. Andriole
SFStephen J. Freedland
Stephen J. Freedland
Background: Studies suggest that obesity is associated with lower risk of prostate cancer but more aggressive cancers. As obesity lowers PSA levels, these observations may be influenced by detection bias. We examined the association between obesity and risk of low- and high-grade prostate cancer in REDUCE, in which biopsies were largely independent of PSA. Methods: The REDUCE study tested dutasteride for prostate cancer risk reduction in men with a PSA of 2.5 to 10.0 ng/mL and a negative biopsy. Study participants included 6,729 men who underwent at least one on-study biopsy. The association between baseline body mass index (BMI <25 kg/m2 normal weight; 25–29.9 kg/m2 overweight; and ≥30 kg/m2 obese) and risk of high-grade (Gleason ≥7) or low-grade prostate cancer (Gleason <7) versus no prostate cancer was examined using multinomial logistic regression. Results: Overall, 1,739 men (27%) were normal weight, 3,384 (53%) overweight, and 1,304 (20%) were obese. Obesity was associated with lower risk of low-grade prostate cancer in both univariable (OR, 0.74; P = 0.001) and multivariable analyses (OR, 0.79; P = 0.01). In univariable analysis, obesity was not associated with high-grade prostate cancer (OR, 1.08; P = 0.50). However, in multivariable analysis, obesity was associated with increased risk of high-grade prostate cancer (OR, 1.28; P = 0.042). This analysis was not able to address how obesity may influence prostate cancer progression. Conclusions: Obesity is associated with decreased risk of low-grade and increased risk of high-grade prostate cancer. These data provide further support to the hypothesis that obesity is associated with aggressive prostate cancer. Impact: Obesity is linked with aggressive prostate cancer. Avoiding obesity may prevent the risk of developing high-grade prostate cancer. Cancer Epidemiol Biomarkers Prev; 23(12); 2936–42. ©2014 AACR.